Related Experiment Video
Updated: Apr 27, 2026
11:33
Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
12.7K
Kenny-Caffey syndrome type 1.
Tony El Jabbour1, Tarek Aboursheid2, Mohammad Baraa Keifo2
1Department of Anatomic Pathology, Faculty of Medicine, Lebanese University, Lebanon, Syria.
Avicenna Journal of Medicine
|July 2, 2014
Summary
Kenny-Caffey syndrome type 1, a rare skeletal disorder, was diagnosed in a 7-month-old girl. The case highlights characteristic symptoms including growth retardation, distinctive facial features, and hypoparathyroidism.
Area of Science:
- Genetics and Developmental Biology
- Pediatric Endocrinology
- Skeletal Dysplasias
Background:
- Kenny-Caffey syndrome type 1 (KCS1) is an autosomal recessive skeletal dysplasia.
- KCS1 is characterized by intrauterine growth retardation, postnatal short stature, and characteristic facial features.
- Hypoparathyroidism is a common endocrine complication associated with KCS1.
Observation:
- A 7-month-old female infant presented with significant growth retardation and dysmorphic facial features.
- Clinical examination revealed features consistent with Kenny-Caffey syndrome type 1.
- Laboratory investigations confirmed the presence of hypoparathyroidism.
Findings:
- The case presentation aligns with the established diagnostic criteria for Kenny-Caffey syndrome type 1.
- The patient exhibited severe short stature and distinctive craniofacial anomalies.
- Biochemical analysis confirmed hypocalcemia and inappropriately low parathyroid hormone levels, indicative of hypoparathyroidism.
Implications:
- This case reinforces the importance of recognizing KCS1 in infants with growth failure and dysmorphic features.
- Early diagnosis and management of hypoparathyroidism are crucial for preventing long-term complications such as seizures and developmental delay.
- Further research into the genetic basis and therapeutic strategies for KCS1 is warranted.
Related Concept Videos
01:12Type I Diabetes I: Introduction
41
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
41
01:20Inborn Errors of Metabolism
1.1K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
01:05Type IV Collagen of Basal Lamina
2.5K
Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
A type IV collagen molecule has six alpha chains which can...
2.5K
01:26Type I Diabetes II: Pathophysiology
59
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
59
01:19Type I Diabetes III: Clinical Manifestations
21
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
21
01:19Cushing Syndrome II: Pathophysiology
22
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
22